chr21-26930035-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_007038.5(ADAMTS5):c.2076G>A(p.Leu692=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00117 in 1,613,926 control chromosomes in the GnomAD database, including 23 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0064 ( 11 hom., cov: 32)
Exomes 𝑓: 0.00063 ( 12 hom. )
Consequence
ADAMTS5
NM_007038.5 synonymous
NM_007038.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -6.85
Genes affected
ADAMTS5 (HGNC:221): (ADAM metallopeptidase with thrombospondin type 1 motif 5) This gene encodes a member of the ADAMTS (a disintegrin and metalloproteinase with thrombospondin motifs) protein family. Members of the family share several distinct protein modules, including a propeptide region, a metalloproteinase domain, a disintegrin-like domain, and a thrombospondin type 1 (TS) motif. Individual members of this family differ in the number of C-terminal TS motifs, and some have unique C-terminal domains. The encoded preproprotein is proteolytically processed to generate the mature enzyme. This enzyme contains two C-terminal TS motifs and functions as an aggrecanase that cleaves aggrecan, a major proteoglycan of cartilage, and may mediate cartilage destruction in osteoarthritis. [provided by RefSeq, Feb 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BP6
Variant 21-26930035-C-T is Benign according to our data. Variant chr21-26930035-C-T is described in ClinVar as [Benign]. Clinvar id is 781593.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-6.85 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00637 (969/152132) while in subpopulation AFR AF= 0.0224 (931/41528). AF 95% confidence interval is 0.0212. There are 11 homozygotes in gnomad4. There are 440 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High AC in GnomAd4 at 969 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ADAMTS5 | NM_007038.5 | c.2076G>A | p.Leu692= | synonymous_variant | 7/8 | ENST00000284987.6 | |
ADAMTS5 | XM_047440680.1 | c.1908G>A | p.Leu636= | synonymous_variant | 6/7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ADAMTS5 | ENST00000284987.6 | c.2076G>A | p.Leu692= | synonymous_variant | 7/8 | 1 | NM_007038.5 | P1 | |
ENST00000426771.1 | n.235-9581C>T | intron_variant, non_coding_transcript_variant | 3 | ||||||
ADAMTS5 | ENST00000652031.1 | c.*807G>A | 3_prime_UTR_variant, NMD_transcript_variant | 8/9 |
Frequencies
GnomAD3 genomes AF: 0.00635 AC: 966AN: 152014Hom.: 11 Cov.: 32
GnomAD3 genomes
AF:
AC:
966
AN:
152014
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00170 AC: 426AN: 251052Hom.: 3 AF XY: 0.00122 AC XY: 165AN XY: 135642
GnomAD3 exomes
AF:
AC:
426
AN:
251052
Hom.:
AF XY:
AC XY:
165
AN XY:
135642
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000631 AC: 923AN: 1461794Hom.: 12 Cov.: 30 AF XY: 0.000539 AC XY: 392AN XY: 727208
GnomAD4 exome
AF:
AC:
923
AN:
1461794
Hom.:
Cov.:
30
AF XY:
AC XY:
392
AN XY:
727208
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00637 AC: 969AN: 152132Hom.: 11 Cov.: 32 AF XY: 0.00592 AC XY: 440AN XY: 74378
GnomAD4 genome
AF:
AC:
969
AN:
152132
Hom.:
Cov.:
32
AF XY:
AC XY:
440
AN XY:
74378
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
3
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 09, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at